Early co-stimulation blocking immune suppression relied on using an anti-CD154 antibody, which was known to promote thrombocytopenia in allotransplantation due to platelet CD154 expression and Fc-receptor activation (80, 81). The gene discussed is CD40LG; the disease is Thrombocytopenia.